Real world experience of palbociclib in hormone receptor-positive metastatic breast cancer.

被引：3
|
作者：
Malik, Faizan
Ali, Naveed
Jafri, Syed Imran Mustafa
Sundermeyer, Mark L.
Seidman, Michael Jeffrey
Fidler, Christian Joseph
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e18094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18094
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: a multicenter real-world study in the northwest of China
    Jiao Yang
    Bing Zhao
    Xiaoling Ling
    Donghui Li
    Jiuda Zhao
    Yonggang Lv
    Guangxi Wang
    Xinlan Liu
    Nanlin Li
    Jin Yang
    BMC Cancer, 23
  • [32] Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: a multicenter real-world study in the northwest of China
    Yang, Jiao
    Zhao, Bing
    Ling, Xiaoling
    Li, Donghui
    Zhao, Jiuda
    Lv, Yonggang
    Wang, Guangxi
    Liu, Xinlan
    Li, Nanlin
    Yang, Jin
    BMC CANCER, 2023, 23 (01)
  • [33] Real world evidence of palbociclib use in metastatic hormone positive HER negative metastatic breast cancer in Indian population
    Agrawal, C.
    Doval, D.
    Agarwal, A.
    Goyal, P.
    Baghmar, S.
    Talwar, V.
    Batra, U.
    Goyal, S.
    Sinha, R.
    Archana, S.
    Jain, P.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S103 - S103
  • [34] PALBOCICLIB IN THE TREATMENT OF METASTATIC BREAST CANCER. INSTITUTIONAL EXPERIENCE
    Mainella, A.
    Vigo, S.
    Marmissolle, F.
    Price, P.
    Sansano, M.
    Lujan, M. L.
    Dominguez, M. P.
    Zapata Caamano, G.
    Menna, E.
    Giacomi, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A624 - A624
  • [35] Risk Factors for Palbociclib-Induced Early Developing Neutropenia in Patients with Hormone Receptor-Positive Metastatic Breast Cancer
    Lee, Yeonhong
    Lee, Dayae
    Seo, Inyoung
    Chae, Heejung
    Sim, Sung Hoon
    Lee, Keun Seok
    Gwak, Hye Sun
    CANCERS, 2023, 15 (10)
  • [36] Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer
    Turner, Nicholas C.
    Liu, Yuan
    Zhu, Zhou
    Loi, Sherene
    Colleoni, Marco
    Loibl, Sibylle
    DeMichele, Angela
    Harbeck, Nadia
    Andre, Fabrice
    Bayar, Mohamed Amine
    Michiels, Stefan
    Zhang, Zhe
    Giorgetti, Carla
    Arnedos, Monica
    Bartlett, Cynthia Huang
    Cristofanilli, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (14) : 1169 - +
  • [37] Real-World Experience of Palbociclib-Induced Adverse Events and Compliance With Complete Blood Count Monitoring in Women With Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer
    Watson, Geoffrey Alan
    Deac, Dana
    Aslam, Razia
    O'Dwyer, Richard
    Tierney, Antonia
    Sukor, Sue
    Kennedy, John
    CLINICAL BREAST CANCER, 2019, 19 (01) : E186 - E194
  • [38] A single-arm phase II trial of palbociclib in combination with tamoxifen as first-line therapy for metastatic hormone receptor-positive breast cancer.
    Danciu, Oana Cristina
    Hoskins, Kent
    Truica, Cristina I.
    Blaes, Anne Hudson
    Tamkus, Deimante
    Rana, Jatin
    Tandra, Pavankumar
    Green, Lauren
    Yu, Menggang
    Zhao, Qianqian
    Toppmeyer, Deborah
    O'Regan, Ruth
    Wisinski, Kari Braun
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [39] Real World Experience of Second-Line Treatment Strategies after Palbociclib and Letrozole: Overall Survival in Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
    Kim, Ji-Yeon
    Shin, Junghoon
    Ahn, Jin Seok
    Park, Yeon Hee
    Im, Young-Hyuck
    CANCERS, 2023, 15 (13)
  • [40] Sacituzumab Govitecan in Hormone Receptor-Positive Metastatic Breast Cancer Reply
    Rugo, Hope S.
    Bardia, Aditya
    Tolaney, Sara M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (08) : 1631 - +
12345